Senti Biosciences Holdings, Inc. - Common Stock (NQ:SNTI)

0.1806 -0.0074 (-3.94%)

Delayed Quote Updated: 10:10 AM EST, Nov 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Senti Biosciences Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 07, 2024

Via Benzinga

Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia

May 13, 2024

From Senti Biosciences, Inc.

Via GlobeNewswire

SNTI Stock Earnings: Senti Biosciences Reported Results for Q1 2024 ↗

May 09, 2024

Senti Biosciences just reported results for the first quarter of 2024.

Via InvestorPlace

Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights

May 09, 2024

From Senti Biosciences, Inc.

Via GlobeNewswire

Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)

April 30, 2024

From Senti Biosciences, Inc.

Via GlobeNewswire

SNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023 ↗

March 21, 2024

SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights

March 21, 2024

From Senti Biosciences, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 22, 2024

Via Benzinga

Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program

January 05, 2024

From Senti Biosciences, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 25, 2023

Via Benzinga

Why Is Blood Cancer Focused Senti Biosciences Stock Trading Higher Today? ↗

December 22, 2023

Senti Biosciences Inc (NASDAQ: SNTI) received FDA clearance for its Investigational New Drug (IND) application for SENTI-202, an off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cell...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 22, 2023

Via Benzinga

Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia

December 22, 2023

From Senti Biosciences, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 12, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

December 12, 2023

Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 07, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

November 16, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 13, 2023

Via Benzinga

Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates

November 13, 2023

From Senti Biosciences, Inc.

Via GlobeNewswire

Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal ↗

November 11, 2023

Eccogene, a Shanghai-Boston biotech, out-licensed global rights (ex-China) for its novel small molecule GLP-1 agonist to AstraZeneca in a $2 billion blockbuster deal. Eccogene will receive $185 million...

Via Talk Markets

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 08, 2023

Via Benzinga

Crude Oil Falls Sharply; Datadog Shares Spike Higher ↗

November 07, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1% on Tuesday The Dow traded up 0.21% to 34,166.89 while the NASDAQ rose 1.09% to 13,666.65. The S&P 500...

Via Benzinga

Topics Stocks

Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 07, 2023

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 07, 2023

Via Benzinga

Nasdaq Jumps 100 Points; US Trade Deficit Widens In September ↗

November 07, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Tuesday The Dow traded up 0.19% to 34,159.14 while the NASDAQ rose 0.84% to 13,631.99. The...

Via Benzinga

Topics Stocks

US Stocks Mixed; D.R. Horton Earnings Top Views ↗

November 07, 2023

U.S. stocks traded mixed this morning, with the Dow Jones falling around 50 points on Tuesday Following the market opening Tuesday, the Dow traded down 0.18% to 34,035.79 while the NASDAQ rose 0.14% to...

Via Benzinga

Topics Stocks

Why Is Cell & Gene Therapy-Focused Senti Biosciences Stock Trading Higher Today? ↗

November 07, 2023

Senti Biosciences Inc (NASDAQ: SNTI) announced a new strategic collaboration with Celest Therapeutics (Shanghai) Co Ltd, a China-based biotechnology company, for the clinical development of SENTI-301A...

Via Benzinga

Why Is Alto Ingredients (ALTO) Stock Down 45% Today? ↗

November 07, 2023

Alto Ingredients stock is falling on Tuesday after the company released a mixed earnings report for the third quarter of the year.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.